Suchergebnisse - "Greig, Nigel H"

PubPharm (621)

51

Repurposing Pomalidomide as a Neuroprotective Drug : Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16

52

Exploring the Recent Trends in Management of Dementia and Frailty : Focus on Diagnosis and Treatment

enthalten in: Current medicinal chemistry | 2022

von Rahman, M. | Mim, S. | Islam, M. | +8

53

Codon Usage Bias Correlates With Gene Length in Neurodegeneration Associated Genes

enthalten in: Frontiers in neuroscience | 2022

von Khandia, R. | Saeed, M. | Alharbi, A. | +3

54

Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation

enthalten in: Journal of neuroinflammation | 2022

von Bedolla, A. | Taranov, A. | Luo, F. | +8

55

Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation

enthalten in: Journal of neuroinflammation | 2022

von Bedolla, A. | Taranov, A. | Luo, F. | +8

56

Diphtheria toxin induced but not CSF1R inhibitor mediated microglia ablation model leads to the loss of CSF/ventricular spaces in vivo that is independent of cytokine upregulation

enthalten in: Journal of neuroinflammation | 2022

von Bedolla, A. | Taranov, A. | Luo, F. | +8

57

Exploring the Recent Trends in Management of Dementia and Frailty: Focus on Diagnosis and Treatment

enthalten in: Current medicinal chemistry | 2022

von Rahman, M. | Mim, S. | Islam, M. | +8

58

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

enthalten in: Neurotherapeutics | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16

59

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

enthalten in: Neurotherapeutics | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16

60

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

enthalten in: NeuroRX | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16